Genuine Parts Company Reports Fourth Quarter and Full-Year 2024 Results

Declares Dividend Increase for 69th Consecutive Year Provides 2025 Outlook Fourth Quarter 2024 Highlights — Sales of $5.8 billion — Diluted EPS of $0.96 — Adjusted Diluted EPS of $1.61 Full-Year 2024 Highlights — Sales of $23.5 billion — Diluted EPS of $6.47 — Adjusted Diluted EPS of $8.16 — Cash from Operations of $1.3 […]

Tempur Sealy Completes Name Change to Somnigroup International

Somnigroup International Inc. (NYSE: SGI, “Company” or “Somnigroup”), formerly Tempur Sealy International, today announced the completion of its name change. Shares of Somnigroup common stock trade on the New York Stock Exchange under the ticker symbol “SGI.” Scott Thompson, Somnigroup Chairman and CEO said, “Somnigroup is the world's largest bedding company, with superior capabilities in

Visteon Announces 2024 Financial Results and 2025 Outlook

Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2024 financial results. Highlights include: https://mma.prnewswire.com/media/2621749/Visteon_Logo.jpg — $939 million net sales in Q4 and $3,866 million for the full year — Net income of $122 million in Q4 and $274 million for the full year, including a $49 million non-cash U.S. tax benefit — Adjusted

DraftKings Announces Launch of $500 Million Term Loan B Facility

(NASDAQ:DKNG), BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced the launch of syndication for a proposed senior secured term loan B credit facility (the “Term Loan B”) in an aggregate principal amount of $500 million. The consummation of the Term Loan B is subject to market

PharmaBlock Launches Commercial GMP Workshop 503 at Zhejiang Site

PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE) has announced the official launch of its commercial GMP Workshop 503 (W503) at PharmaBlock Zhejiang. The new workshop significantly enhances production capacity and further refines the high-standard GMP manufacturing system, along with advanced automation and the lean operation model, thereby bolstering the company's capabilities in late-phase and commercial

Timken to Participate in Upcoming Investor Conferences

The Timken Company (NYSE: TKR; www.timken.com), a global technology leader in engineered bearings and industrial motion, will participate in three upcoming investor conferences. Philip D. Fracassa, executive vice president and chief financial officer and Neil Frohnapple, vice president of investor relations, will participate in the Evercore ISI Industrial Conference on Tuesday, March 4, 2025, the

Reliance, Inc. Announces Upcoming Conference Participation

(NYSE:RS), SCOTTSDALE, Ariz., Feb. 18, 2025 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE: RS) announced today that its management team will participate in the following upcoming investor conferences: The BMO 2025 Global Metals, Mining & Critical Minerals Conference on Wednesday, February 26, 2025 in Hollywood, Florida. Karla Lewis, President and Chief Executive Officer, is scheduled to

ARK Wealth Management’s Latest CIO Report Emphasizes the Power of Elimination as Investors Brace For Heightened Volatility

— ARK CIO research shows a paradigm shift in wealth management, moving beyond safety, liquidity, and returns toward a holistic, value-driven approach that prioritizes preservation over maximization. — The Report introduces a three-tier strategic asset allocation framework: establishing a risk buffer, fortifying core holdings, and capturing growth opportunities. — Insights combine deep industry knowledge with

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

(NASDAQ:SLDB), — Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% (N=3) and significant improvements in multiple additional muscle health biomarkers observed support the potential of SGT-003 as a next-generation, best-in-class Duchenne muscular dystrophy gene therapy candidate —— Encouraging early signals of

IGT Achieves Improved ESG Score from FTSE Russell

Company ranks in the 97th percentile in the Travel and Leisure sector International Game TechnologyPLC (“IGT”) (NYSE: IGT) announced today that it achieved an environmental, social and governance (“ESG”) Score of 4.3 out of 5.0 from FTSE Russell, positioning IGT in the 97th percentile within the Travel and Leisure sector of FTSE Russell's ESG Scores.

Scroll to Top